DE2962920D1 - Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it - Google Patents

Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it

Info

Publication number
DE2962920D1
DE2962920D1 DE7979104763T DE2962920T DE2962920D1 DE 2962920 D1 DE2962920 D1 DE 2962920D1 DE 7979104763 T DE7979104763 T DE 7979104763T DE 2962920 T DE2962920 T DE 2962920T DE 2962920 D1 DE2962920 D1 DE 2962920D1
Authority
DE
Germany
Prior art keywords
vaccine
attenuated strain
infectious peritonitis
virus
feline infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE7979104763T
Other languages
English (en)
Inventor
Bernarad Fishman
Kevin Joseph O'reilly
Louise Mary Hitchcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE2962920D1 publication Critical patent/DE2962920D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE7979104763T 1978-11-30 1979-11-29 Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it Expired DE2962920D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7846603 1978-11-30

Publications (1)

Publication Number Publication Date
DE2962920D1 true DE2962920D1 (en) 1982-07-08

Family

ID=10501422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE7979104763T Expired DE2962920D1 (en) 1978-11-30 1979-11-29 Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it

Country Status (11)

Country Link
US (1) US4571386A (de)
EP (1) EP0011864B1 (de)
JP (1) JPS5576819A (de)
AT (1) ATE1070T1 (de)
AU (1) AU5329279A (de)
DE (1) DE2962920D1 (de)
DK (1) DK507079A (de)
ES (1) ES8107025A1 (de)
HU (1) HU181993B (de)
NZ (1) NZ192270A (de)
ZA (1) ZA796476B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
AU604682B2 (en) * 1986-02-06 1991-01-03 Cornell Research Foundation Inc. Feline infectious peritonitis vaccine
US5043157A (en) * 1986-02-06 1991-08-27 Cornell Research Foundation, Inc. Feline infectious peritonitis vaccine and method of preparation
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
EP0627936A4 (de) * 1992-02-18 1997-01-02 Parhelion Corp Impfstoff gegen die infektiöse peritonitis bei katzen und methode seiner herstellung.
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
CN114874997B (zh) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猫杯状病毒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (de) * 1962-11-27
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
GB1286250A (en) * 1968-10-08 1972-08-23 Wellcome Found Heteroploid cell lines
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
GB1471262A (en) * 1974-03-25 1977-04-21 C Vet Ltd Virus growth
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
GB1492930A (en) * 1974-10-31 1977-11-23 Afg Ltd Virus growth
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines

Also Published As

Publication number Publication date
US4571386A (en) 1986-02-18
ATE1070T1 (de) 1982-06-15
DK507079A (da) 1980-05-31
ZA796476B (en) 1981-07-29
NZ192270A (en) 1983-05-31
EP0011864A1 (de) 1980-06-11
EP0011864B1 (de) 1982-05-19
AU5329279A (en) 1980-06-05
HU181993B (en) 1983-11-28
ES486442A0 (es) 1980-12-16
JPS5576819A (en) 1980-06-10
ES8107025A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
DE2962920D1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
ES8502871A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral
GB2079786B (en) Production of viral antigens
PT81367A (en) Process for producing oral vaccines using adenovirus as vector
FR2602791B1 (fr) Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
Pay et al. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
AU8014691A (en) Vaccine against lyme disease and a challenge model for evaluating vaccine efficiency
JPS5527178A (en) Live influenza virus vaccine
DE3888290D1 (de) Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung.
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
EP0023731A3 (de) Verfahren zur Herstellung polyvalenter Virus-Impfstoffe in einem Einzelzellsystem, solche polyvalenten Impfstoffe und ihre Verwendung
ZA805849B (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
DE2962921D1 (en) Feline infectious peritonitis vaccine and process for its preparation
DE2966648D1 (en) Vaccine against diseases caused by reo viruses, combined vaccine with newcastle disease virus, process for preparing them and reo virus strain used for their preparation
JPS5739350A (en) Preparation of toxoplasma antigen
ATE18135T1 (de) Verfahren zur herstellung von einem verbessertem mutantenstamm von bordetella bronchiseptica und diesen enthaltendes lebendes attenuiertes vakzin.
SE8205247L (sv) Fiskvacciner
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
FR2290220A2 (fr) Nouveau vaccin antirabique

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee